Phenotypic Assessment of Endothelial Microparticles in Diabetic and Nondiabetic Men with Erectile Dysfunction
- 1 June 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (6) , 1436-1442
Abstract
Endothelial microparticles (EMPs) may play a role as biomarkers of vascular injury. EMPs are higher in men with diabetes diabetic men with erectile dysfunction (ED) than in nondiabetic potent men. The aim of this study was to quantize different phenotypic circulating EMP levels among diabetic and nondiabetic patients with ED, and to determine whether EMPs are released as a result of activation or apoptosis. We studied 30 type 2 diabetic and 24 nondiabetic subjects with symptomatic ED from at least 6 months, and 20 nondiabetic men without ED matched for age and weight with diabetic and nondiabetic subjects. Erectile function was assessed by completing the International Index of Erectile Function (IEEF)-5, which consists of Items 5, 15, 4, 2, and 7 from the full-scale IIEF-15. A score of 21 or less indicates the presence of ED. EMP levels in plasma were quantified by flow cytometry. Markers for apoptosis (platelet/endothelial cell adhesion molecule 1/CD31 antigen) and activation (E-selectin/CD62E antigen) were compared. Endothelium-dependent flow-mediated dilation (FMD) was evaluated in the right brachial artery with a high-resolution ultrasound machine following reactive hyperemia. Diabetic patients were found to have the highest levels of EMP31+; diabetic and nondiabetic men with ED were found to have significantly higher levels of EMP62+ than nondiabetic men without ED. The EMP62/EMP31 ratio, an index of endothelial activation (high ratio) or apoptosis (low ratio), was lowest in diabetic men with ED (0.20). In the whole group of 54 men with ED (diabetic and nondiabetic), there was an inverse correlation between FMD and the number of circulating EMPs (P < 0.05). The presence of diabetes in subjects with ED is associated with a different pattern of endothelial cell injury. The phenotypic assessment of EMPs in diabetic patients with ED is consistent with increased apoptotic activity.Keywords
This publication has 30 references indexed in Scilit:
- Endothelial Microparticle Levels Are Similar in Acute Ischemic Stroke and Stroke Mimics Due to Activation and Not Apoptosis/NecrosisAcademic Emergency Medicine, 2007
- Erectile Dysfunction Severity Might Be Associated with Poor Cardiovascular Prognosis in Diabetic MenThe Journal of Sexual Medicine, 2007
- Erectile Dysfunction—An Observable Marker of Diabetes Mellitus? A Large National Epidemiological StudyJournal of Urology, 2006
- Erectile Dysfunction and Subsequent Cardiovascular DiseaseJAMA, 2005
- Phenotypic Assessment of Endothelial Microparticles in Patients with Heart Failure and After Heart Transplantation: Switch From Cell Activation to ApoptosisThe Journal of Heart and Lung Transplantation, 2005
- Endothelial dysfunction links erectile dysfunction to heart diseaseInternational Journal Of Clinical Practice, 2005
- Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trialsDiabetologia, 2004
- Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic PatientsCirculation, 2004
- Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosisThrombosis Research, 2003
- Erectile and endothelial dysfunction in Type II diabetes: a possible linkDiabetologia, 2001